# Kite Pharma, Inc. – FDA Inspection, Aug 20, 2019

Source: https://www.keypedia.com/records/fda_inspections/kite-pharma-inc/76901832-4400-44b6-9915-b8aa6c598211
Source feed: FDA_Inspections

> FDA inspection 1100058 of Kite Pharma, Inc., August 20, 2019. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR parts 211 and 600. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1100058
- Company Name: Kite Pharma, Inc.
- Inspection Date: 2019-08-20
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 3

## Related Documents

- [FDA Inspection 1279894 - 2025-08-27](https://www.keypedia.com/records/fda_inspections/kite-pharma-inc/6c854143-66e4-4bfa-b0da-a4e4e9b83d60)
- FDA Inspection 1155166 - 2021-10-22
- [FDA Inspection 1015808 - 2017-06-16](https://www.keypedia.com/records/fda_inspections/kite-pharma-inc/edd81dfc-f202-4cbe-8592-4d5b2bf6e545)

## Related Officers

- [Gene D. Arcy](https://www.keypedia.com/people/gene-d-arcy/a2def947-65fb-4056-84e2-1f89cf944cf0)
- [FDA Associated Person](https://www.keypedia.com/people/scott-t-ballard/09b2ae9a-3b30-45bd-bac1-437365e938da)

Company: https://www.keypedia.com/companies/kite-pharma-inc/5bf88060-db53-466b-9a1c-85be7984894f

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d